A MULTICENTER, DOUBLE-BLIND, PHASE III, ADJUVANT-CONTROLLED STUDY OF THE EFFECT OF 10 UNITS OF HIV-1 IMMUNOGEN (REMUNE) COMPARED TO INCOMPLETE FREUND'S ADJUVANT (IFA) ALONE EVERY 12 WEEKS ON AIDS-FREE SURVIVAL IN SUBJECTS WITH HIV INFECTION AND CD4 T-LYMPHOCYTES BETWEEN 300 AND 549 CELLS/MICROL REGA: